JP6661626B2 - レーザーエネルギーを送達するための凸状コンタクトプローブ - Google Patents
レーザーエネルギーを送達するための凸状コンタクトプローブ Download PDFInfo
- Publication number
- JP6661626B2 JP6661626B2 JP2017520762A JP2017520762A JP6661626B2 JP 6661626 B2 JP6661626 B2 JP 6661626B2 JP 2017520762 A JP2017520762 A JP 2017520762A JP 2017520762 A JP2017520762 A JP 2017520762A JP 6661626 B2 JP6661626 B2 JP 6661626B2
- Authority
- JP
- Japan
- Prior art keywords
- eye
- therapeutic
- probe
- laser
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000523 sample Substances 0.000 title claims description 133
- 230000001225 therapeutic effect Effects 0.000 claims description 148
- 238000011282 treatment Methods 0.000 claims description 107
- 239000000835 fiber Substances 0.000 claims description 46
- 208000010412 Glaucoma Diseases 0.000 claims description 21
- 238000005345 coagulation Methods 0.000 claims description 3
- 230000015271 coagulation Effects 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 230000035876 healing Effects 0.000 claims 2
- 210000001508 eye Anatomy 0.000 description 266
- 230000001886 ciliary effect Effects 0.000 description 68
- 238000005286 illumination Methods 0.000 description 67
- 238000000034 method Methods 0.000 description 51
- 230000004410 intraocular pressure Effects 0.000 description 38
- 210000001519 tissue Anatomy 0.000 description 33
- 230000003287 optical effect Effects 0.000 description 22
- 230000033001 locomotion Effects 0.000 description 20
- 239000013307 optical fiber Substances 0.000 description 20
- 210000003786 sclera Anatomy 0.000 description 19
- 210000004087 cornea Anatomy 0.000 description 16
- 238000013532 laser treatment Methods 0.000 description 15
- 210000002159 anterior chamber Anatomy 0.000 description 13
- 210000001742 aqueous humor Anatomy 0.000 description 13
- 210000004240 ciliary body Anatomy 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- 230000000007 visual effect Effects 0.000 description 12
- 238000010408 sweeping Methods 0.000 description 11
- 238000001356 surgical procedure Methods 0.000 description 10
- 230000006378 damage Effects 0.000 description 8
- 230000000649 photocoagulation Effects 0.000 description 8
- 230000009467 reduction Effects 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 210000001747 pupil Anatomy 0.000 description 6
- 238000007373 indentation Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000001585 trabecular meshwork Anatomy 0.000 description 5
- 206010021118 Hypotonia Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000007379 Muscle Hypotonia Diseases 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000000795 conjunctiva Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 238000002690 local anesthesia Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 201000004569 Blindness Diseases 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- 230000004509 aqueous humor production Effects 0.000 description 3
- 230000001066 destructive effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000003685 thermal hair damage Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 201000002862 Angle-Closure Glaucoma Diseases 0.000 description 1
- 206010053781 Anterior chamber cell Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010996 Corneal degeneration Diseases 0.000 description 1
- 206010011039 Corneal perforation Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 206010048851 Necrotising scleritis Diseases 0.000 description 1
- 206010030348 Open-Angle Glaucoma Diseases 0.000 description 1
- 206010061323 Optic neuropathy Diseases 0.000 description 1
- LRJOMUJRLNCICJ-JZYPGELDSA-N Prednisolone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O LRJOMUJRLNCICJ-JZYPGELDSA-N 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001384 anti-glaucoma Effects 0.000 description 1
- 229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 229960002470 bimatoprost Drugs 0.000 description 1
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000004781 bullous keratopathy Diseases 0.000 description 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 description 1
- 229940127243 cholinergic drug Drugs 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000004406 elevated intraocular pressure Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960001160 latanoprost Drugs 0.000 description 1
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000018769 loss of vision Diseases 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000003547 miosis Effects 0.000 description 1
- 239000003604 miotic agent Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 208000023922 necrotizing scleritis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000001749 optic atrophy Diseases 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 208000020911 optic nerve disease Diseases 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 229960002800 prednisolone acetate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000003994 retinal ganglion cell Anatomy 0.000 description 1
- 238000011268 retreatment Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008337 systemic blood flow Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/00821—Methods or devices for eye surgery using laser for coagulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/009—Auxiliary devices making contact with the eyeball and coupling in laser light, e.g. goniolenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00865—Sclera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00868—Ciliary muscles or trabecular meshwork
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00885—Methods or devices for eye surgery using laser for treating a particular disease
- A61F2009/00891—Glaucoma
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Laser Surgery Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462018345P | 2014-06-27 | 2014-06-27 | |
| US62/018,345 | 2014-06-27 | ||
| PCT/US2015/038150 WO2015200875A1 (en) | 2014-06-27 | 2015-06-26 | Convex contact probe for the delivery of laser energy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017520378A JP2017520378A (ja) | 2017-07-27 |
| JP2017520378A5 JP2017520378A5 (enExample) | 2018-07-26 |
| JP6661626B2 true JP6661626B2 (ja) | 2020-03-11 |
Family
ID=54929319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017520762A Active JP6661626B2 (ja) | 2014-06-27 | 2015-06-26 | レーザーエネルギーを送達するための凸状コンタクトプローブ |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9700461B2 (enExample) |
| EP (1) | EP3160379B1 (enExample) |
| JP (1) | JP6661626B2 (enExample) |
| CN (1) | CN107072712B (enExample) |
| WO (1) | WO2015200875A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8945103B2 (en) | 2007-10-30 | 2015-02-03 | Iridex Corporation | Contact probe for the delivery of laser energy |
| US9962291B2 (en) * | 2012-05-25 | 2018-05-08 | Ojai Retinal Technology, Llc | System and process for neuroprotective therapy for glaucoma |
| US9629749B2 (en) * | 2014-02-27 | 2017-04-25 | Iridex Corporation | Illuminated treatment probe for delivering laser energy |
| US10758118B2 (en) * | 2016-06-30 | 2020-09-01 | Iridex Corporation | Handheld ophthalmic laser system with replaceable contact tips and treatment guide |
| CN110325153B (zh) | 2017-02-15 | 2022-03-29 | 艾瑞黛克斯公司 | 用于使用广域光源来诊治眼睛的方法和眼罩装置 |
| US11058890B2 (en) | 2017-02-15 | 2021-07-13 | Iridex Corporation | Method and apparatus for cyclo-scanner using surface emitting lasers or LEDs |
| EP3684310A4 (en) * | 2017-09-21 | 2021-06-16 | ALeyeGN Technologies LLC | METHOD AND DEVICE FOR TREATMENT OF ANGLE OPENING GLUCOMA |
| JP6900006B2 (ja) * | 2018-02-14 | 2021-07-07 | 東芝デバイス&ストレージ株式会社 | チップ移載部材、チップ移載装置、およびチップ移載方法 |
| EP3773371A4 (en) * | 2018-03-29 | 2022-01-05 | Lumenis Ltd | DEVICE AND METHOD FOR TREATMENT OF DRY EYE |
| US10821024B2 (en) | 2018-07-16 | 2020-11-03 | Vialase, Inc. | System and method for angled optical access to the irido-corneal angle of the eye |
| US11246754B2 (en) | 2018-07-16 | 2022-02-15 | Vialase, Inc. | Surgical system and procedure for treatment of the trabecular meshwork and Schlemm's canal using a femtosecond laser |
| US11173067B2 (en) | 2018-09-07 | 2021-11-16 | Vialase, Inc. | Surgical system and procedure for precise intraocular pressure reduction |
| US11986424B2 (en) | 2018-07-16 | 2024-05-21 | Vialase, Inc. | Method, system, and apparatus for imaging and surgical scanning of the irido-corneal angle for laser surgery of glaucoma |
| US11110006B2 (en) | 2018-09-07 | 2021-09-07 | Vialase, Inc. | Non-invasive and minimally invasive laser surgery for the reduction of intraocular pressure in the eye |
| US10821023B2 (en) | 2018-07-16 | 2020-11-03 | Vialase, Inc. | Integrated surgical system and method for treatment in the irido-corneal angle of the eye |
| US12245974B2 (en) | 2018-07-16 | 2025-03-11 | Vialase, Inc. | System and method for clearing an obstruction from the path of a surgical laser |
| US10369049B1 (en) | 2018-08-17 | 2019-08-06 | Iridex Corporation | Probes having fiber taper and fluid collection channel for ophthalmic laser treatment |
| WO2020040690A1 (en) * | 2018-08-23 | 2020-02-27 | Ocuvix Pte. Ltd. | Paralimbal laser probe |
| WO2020093060A2 (en) | 2018-11-02 | 2020-05-07 | Aleyegn Technologies Llc | Laser therapy for treatment and prevention of eye diseases |
| US11745024B2 (en) | 2018-12-27 | 2023-09-05 | Iridex Corporation | Electrical methods and devices for ophthalmic treatment |
| US11234866B2 (en) * | 2019-04-19 | 2022-02-01 | Elios Vision, Inc. | Personalization of excimer laser fibers |
| AU2020401393A1 (en) | 2019-12-14 | 2022-08-04 | Vialase, Inc. | Near eye reflective devices for diagnostic and therapeutic ophthalmic procedures |
| US11564567B2 (en) | 2020-02-04 | 2023-01-31 | Vialase, Inc. | System and method for locating a surface of ocular tissue for glaucoma surgery based on dual aiming beams |
| US11612315B2 (en) | 2020-04-09 | 2023-03-28 | Vialase, Inc. | Alignment and diagnostic device and methods for imaging and surgery at the irido-corneal angle of the eye |
| US12465522B2 (en) | 2020-12-07 | 2025-11-11 | Iridex Corporation | Methods and probes for intrascleral laser surgery |
| DE102020134738B4 (de) * | 2020-12-22 | 2024-10-10 | A.R.C. Laser Gmbh | Augenbehandlungsvorrichtung, insbesondere für Glaukome |
| CN112674932A (zh) * | 2021-01-12 | 2021-04-20 | 昆明医科大学第一附属医院 | 用于治疗开角型青光眼的光生物调节治疗仪及使用方法 |
| DE102021130135A1 (de) | 2021-11-18 | 2023-05-25 | A.R.C. Laser Gmbh | Ophthalmische Maske und ophthalmische Vorrichtung |
| US12002567B2 (en) | 2021-11-29 | 2024-06-04 | Vialase, Inc. | System and method for laser treatment of ocular tissue based on patient biometric data and apparatus and method for determining laser energy based on an anatomical model |
| US20230181366A1 (en) | 2021-12-13 | 2023-06-15 | Mehmet Melek | Scanning Ophthalmic Transscleral Laser Probe System |
| US20240074902A1 (en) * | 2022-09-02 | 2024-03-07 | Alcon Inc. | Devices and methods for improved followability in laser-based ocular procedures |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5151098A (en) * | 1990-07-23 | 1992-09-29 | Hanspeter Loertscher | Apparatus for controlled tissue ablation |
| JPH06505906A (ja) * | 1991-03-13 | 1994-07-07 | アイリス メディカル インスツルメンツ インコーポレイテッド | レーザ式毛様体光凝固術のための接触プローブ |
| US5217452A (en) * | 1992-05-18 | 1993-06-08 | Donnell Francis E O | Transscleral laser treatment of subretinal neovascularization |
| US5549632A (en) | 1992-10-26 | 1996-08-27 | Novatec Laser Systems, Inc. | Method and apparatus for ophthalmic surgery |
| US5549596A (en) | 1993-07-07 | 1996-08-27 | The General Hospital Corporation | Selective laser targeting of pigmented ocular cells |
| DE9409616U1 (de) * | 1994-06-17 | 1994-08-04 | Fa. Carl Zeiss, 89520 Heidenheim | Applikator zur Behandlung eines erhöhten Augeninnendruckes mittels Laserstrahlung |
| JP2794624B2 (ja) * | 1994-11-28 | 1998-09-10 | ソニー株式会社 | レーザープローブ |
| US6059772A (en) | 1995-03-10 | 2000-05-09 | Candela Corporation | Apparatus and method for treating glaucoma using a gonioscopic laser trabecular ablation procedure |
| US5968033A (en) * | 1997-11-03 | 1999-10-19 | Fuller Research Corporation | Optical delivery system and method for subsurface tissue irradiation |
| JP2002282298A (ja) * | 2001-03-23 | 2002-10-02 | Nidek Co Ltd | 毛様体光凝固プローブ及びこれを備える眼科用レーザ装置 |
| WO2006015016A2 (en) | 2004-07-30 | 2006-02-09 | Massachusetts Eye And Ear Infirmary | Photodynamic therapy and compositions for treating ocular glaucoma |
| US7771417B2 (en) | 2005-02-24 | 2010-08-10 | Iridex Corporation | Laser system with short pulse characteristics and its methods of use |
| US8945103B2 (en) | 2007-10-30 | 2015-02-03 | Iridex Corporation | Contact probe for the delivery of laser energy |
| US9629749B2 (en) * | 2014-02-27 | 2017-04-25 | Iridex Corporation | Illuminated treatment probe for delivering laser energy |
-
2015
- 2015-06-25 US US14/750,729 patent/US9700461B2/en active Active
- 2015-06-26 JP JP2017520762A patent/JP6661626B2/ja active Active
- 2015-06-26 CN CN201580039232.0A patent/CN107072712B/zh active Active
- 2015-06-26 EP EP15812763.9A patent/EP3160379B1/en active Active
- 2015-06-26 WO PCT/US2015/038150 patent/WO2015200875A1/en not_active Ceased
-
2017
- 2017-06-07 US US15/616,768 patent/US10500094B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20180000638A1 (en) | 2018-01-04 |
| JP2017520378A (ja) | 2017-07-27 |
| CN107072712A (zh) | 2017-08-18 |
| EP3160379A1 (en) | 2017-05-03 |
| HK1232094A1 (en) | 2018-01-05 |
| WO2015200875A1 (en) | 2015-12-30 |
| US9700461B2 (en) | 2017-07-11 |
| EP3160379A4 (en) | 2018-03-14 |
| US10500094B2 (en) | 2019-12-10 |
| US20150374539A1 (en) | 2015-12-31 |
| EP3160379B1 (en) | 2019-06-05 |
| CN107072712B (zh) | 2020-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6661626B2 (ja) | レーザーエネルギーを送達するための凸状コンタクトプローブ | |
| US12213918B2 (en) | Contact probe for the delivery of laser energy | |
| CN101969899B (zh) | 应用高强度聚焦超声波治疗眼病的方法及其设备 | |
| US20200323688A1 (en) | Illuminated Treatment Probe for Delivering Laser Energy | |
| KR102268628B1 (ko) | 안구내 션트의 외부 배치 | |
| CN106999296B (zh) | 用于眼组织交联的喷嘴单元 | |
| Brancato et al. | The erodible mask in photorefractive keratectomy for myopia and astigmatism | |
| WO2016187436A1 (en) | Multifocal, electromagnetic treatment of ocular tissues | |
| JP7116841B2 (ja) | 眼科用レーザー治療のためのファイバーテーパおよび流体収集チャネルを有するプローブ | |
| WO2011083358A1 (en) | Device for treating an ocular pathology by applying doses of laser energy | |
| HK1232094B (en) | Convex contact probe for the delivery of laser energy | |
| Seibold | Emerging Surgical Interventions | |
| Menon | Minimally Invasive Glaucoma Surgery (MIGS) | |
| HK40054520A (en) | Ab externo intraocular shunt placement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170301 |
|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20170424 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20170424 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180615 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180615 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190422 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190514 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190814 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200114 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200212 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6661626 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |